BACH1 and porphyria: It is tempting to speculate that our study also provides a new therapeutic target for these porphyria individuals – for instance, the possibility of knocking down BACH1 specifically in the exocrine pancreas to enhance zymogen levels (Fig. 7A), thereby, alleviating acute episodic abdominal pains.